Entellus Medical Inc (ENTL) Files Form 4 Insider Selling : Timothy B Petrick Sells 3,000 Shares

Entellus Medical Inc (ENTL): Timothy B Petrick , VP, Research and Development of Entellus Medical Inc sold 3,000 shares on Jul 18, 2016. The Insider selling transaction was reported by the company on Jul 19, 2016 to the Securities and Exchange Commission. The shares were sold at $18.15 per share for a total value of $54,447.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 4, 2016, Karen E Peterson (officer ) sold 10,000 shares at $17.00 per share price.On Sep 17, 2015, Brian E Farley (EXECUTIVE CHAIRMAN) sold 5,484 shares at $22.01 per share price.Also, On Sep 3, 2015, James D Surek (VICE PRESIDENT, SALES) sold 15,000 shares at $21.27 per share price.On Feb 4, 2015, Robert S. White (COO) purchased 5,882 shares at $17.00 per share price.

Entellus Medical Inc: On Monday, Jul 18, 2016 heightened volatility was witnessed in Entellus Medical Inc which led to swings in the share price. The shares opened for trading at $18.27 and hit $18.59 on the upside , eventually ending the session at $18.26, with a gain of 0.33% or 0.06 points. The heightened volatility saw the trading volume jump to 1,35,611 shares. The 52-week high of the share price is $24.75 and the company has a market cap of $344 M . The 52-week low of the share price is at $13.72.

Entellus Medical Inc Money Flow Index Chart

Entellus Medical Inc. is a medical technology company. The Company is focused on the design development and commercialization of products for the minimally invasive treatment of patients who are suffering from chronic sinusitis. The Company’s XprESS family of products is used by ear nose and throat (ENT) physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses. Its XprESS family of products includes its XprESS Pro device its XprESS LoProfile device and its XprESS Ultra device. The Company markets its products in the United States and Canada and sells its products through a direct sales force in the United States.

Leave a Reply

Entellus Medical Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Entellus Medical Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.